Candriam S.C.A. Omeros Corp Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 09, 2018	SELL	$9.0 - $20.16 $768,330 - $1.72 Million	-85,370 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$13.26 - $22.86 $106,080 - $182,880	-8,000 Reduced 8.57%	85,370 $1.66 Million
Q3 2017 Nov 03, 2017	BUY	$19.76 - $24.9 $1.84 Million - $2.32 Million	93,370	93,370 $2.02 Million

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $436M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.